Medical device giant Stryker recently disclosed that a sudden cybersecurity incident has restricted access to some of the company's critical information systems and business applications.

Two oil tankers attacked in the Gulf region, pushing oil prices sharply higher at the start of trading

The latest data released by UnitedHealthcare in the United States shows that its pulmonary arterial hypertension treatment drug Tyvaso demonstrates good tolerability, and the drug’s safety profile remains consistent with previous clinical trial results.

PROG Holdings, Inc. announced a comprehensive capital allocation strategy aimed at returning excess capital to shareholders while optimizing its balance sheet.

United Therapeutics announced that the full results of its Teton-2 Phase III clinical trial have been officially published in the authoritative medical journal The New England Journal of Medicine.